Literature DB >> 13866804

Spotted fever vaccine; potency assay by direct challenge of vaccinated mice with toxin of Rickettsia rickettsii.

E J BELL, H G STOENNER.   

Abstract

Entities:  

Keywords:  RICKETTSIA RICKETTSII/immunology; ROCKY MOUNTAIN SPOTTED FEVER/immunology; TOXINS AND ANTITOXINS

Mesh：

Substances：

Year:  1961        PMID： 13866804

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  6 in total

1.  Antigenic heterogeneity in high- and low-virulence strains of Rickettsia rickettsii revealed by monoclonal antibodies.

Authors:  R L Anacker; R H List; R E Mann; D L Wiedbrauk
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

2.  Quantitative analyses of variations in the injury of endothelial cells elicited by 11 isolates of Rickettsia rickettsii.

Authors:  M E Eremeeva; G A Dasch; D J Silverman
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

3.  New assay of protective activity of Rocky Mountain spotted fever vaccines.

Authors:  R L Anacker; R F Smith; R E Mann; M A Hamilton
Journal:  J Clin Microbiol       Date:  1976-09       Impact factor: 5.948

4.  Rhipicephalus sanguineus: vector of a new spotted fever group rickettsia in the United States.

Authors:  W Burgdorfer; D J Sexton; R K Gerloff; R L Anacker; R N Philip; L A Thomas
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

5.  Immunological properties of Rickettsia rickettsii purified by zonal centrifugation.

Authors:  R L Anacker; R K Gerloff; L A Thomas; R E Mann; W D Bickel
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

6.  Detection of Rickettsia rickettsii antibodies in human sera by crossed immunoelectrophoresis.

Authors:  R L Anacker; R N Philip; C M Wilfert; K T Kleeman; L Turner; J N MacCormack; K E Hechemy
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.